Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Accuray ( (ARAY) ) is now available.
Accuray Incorporated reported that its Senior Vice President and Chief Operations Officer, Leonel Peralta, departed the company effective April 26, 2026. The company stated that Peralta’s resignation did not arise from any disagreement with management, the board, or matters related to Accuray’s operations, policies, or practices, signaling a routine leadership transition without disclosed strategic or operational disputes.
The change in the chief operations role may prompt adjustments in day-to-day operational oversight and execution, but the company’s clarification on the absence of disagreements aims to reassure investors, employees, and partners. Stakeholders are likely to focus on how Accuray fills the COO position and maintains continuity in operational strategy following Peralta’s departure.
The most recent analyst rating on (ARAY) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on Accuray stock, see the ARAY Stock Forecast page.
Spark’s Take on ARAY Stock
According to Spark, TipRanks’ AI Analyst, ARAY is a Neutral.
ARAY scores low primarily due to weak financial performance (return to losses and high leverage with a thin equity cushion) and bearish technical trend signals. The latest earnings call further pressures the outlook via a meaningful guidance cut and margin deterioration, partially offset by strong orders/backlog and cost-reduction initiatives. Valuation provides limited support given negative earnings and no dividend yield data.
To see Spark’s full report on ARAY stock, click here.
More about Accuray
Accuray Incorporated operates in the medical technology industry, specializing in radiation therapy systems used for cancer treatment and other conditions. The company focuses on advanced radiosurgery and radiotherapy solutions that enable precise, targeted treatment, serving hospitals, cancer centers, and healthcare providers worldwide.
Average Trading Volume: 1,322,347
Technical Sentiment Signal: Sell
Current Market Cap: $55.22M
For a thorough assessment of ARAY stock, go to TipRanks’ Stock Analysis page.